Elizabeth M. Berry-Kravis, M.D., Ph.D.
Co-Director, Molecular Diagnostics Section of the Genetic Laboratory; Professor, Department of Pediatrics, Rush Medical CollegeElizabeth M. Berry-Kravis’s website
Berry-Kravis established the Fragile X Clinic and Research Program at Rush University Medical Center in 1992, which now provides care to more than 700 patients with FXS. She researches FXS and other neurogenetic diseases, including outcome measures, biomarkers, natural history studies and clinical trials in FXS, PMS, NPC, Angelman syndrome, Rett syndrome, and Down syndrome. She has led the translational effort to develop new models for targeted treatment for FXS.